Peter Honig

Insider Reports History

Entity
Individual
Location
3344 N. Torrey Pines Court, Suite 200, La Jolla, CA
Signature
/s/ Nancy Smith, Attorney-in-Fact for Peter Honig
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Honig:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sesen Bio, Inc. Director Common Stock 40K $23.5K $0.59 Jun 22, 2022 Direct
Sesen Bio, Inc. Director Stock Option 65K Jun 22, 2022 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 34K May 24, 2023 Direct

Insider Reports Filed by Peter Honig

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
CARM Sesen Bio, Inc. Jun 22, 2022 2 $0 4 Jun 24, 2022 Director
KPTI Karyopharm Therapeutics Inc. May 19, 2022 1 $0 4 May 20, 2022 Director
KPTI Karyopharm Therapeutics Inc. Dec 3, 2021 1 $0 4 Dec 7, 2021 Director
KPTI Karyopharm Therapeutics Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director
CARM Sesen Bio, Inc. Jul 20, 2021 1 $0 4 Jul 21, 2021 Director
CARM Sesen Bio, Inc. Jul 20, 2021 0 $0 3 Jul 21, 2021 Director